Your browser doesn't support javascript.
loading
KCND3 potassium channel gene variant confers susceptibility to electrocardiographic early repolarization pattern.
Teumer, Alexander; Trenkwalder, Teresa; Kessler, Thorsten; Jamshidi, Yalda; van den Berg, Marten E; Kaess, Bernhard; Nelson, Christopher P; Bastiaenen, Rachel; De Bortoli, Marzia; Rossini, Alessandra; Deisenhofer, Isabel; Stark, Klaus; Assa, Solmaz; Braund, Peter S; Cabrera, Claudia; Dominiczak, Anna F; Gögele, Martin; Hall, Leanne M; Ikram, M Arfan; Kavousi, Maryam; Lackner, Karl J; Müller, Christian; Münzel, Thomas; Nauck, Matthias; Padmanabhan, Sandosh; Pfeiffer, Norbert; Spector, Tim D; Uitterlinden, Andre G; Verweij, Niek; Völker, Uwe; Warren, Helen R; Zafar, Mobeen; Felix, Stephan B; Kors, Jan A; Snieder, Harold; Munroe, Patricia B; Pattaro, Cristian; Fuchsberger, Christian; Schmidt, Georg; Nolte, Ilja M; Schunkert, Heribert; Pramstaller, Peter P; Wild, Philipp S; van der Harst, Pim; Stricker, Bruno H; Schnabel, Renate B; Samani, Nilesh J; Hengstenberg, Christian; Dörr, Marcus; Behr, Elijah R.
Afiliação
  • Teumer A; Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
  • Trenkwalder T; German Center for Cardiovascular Research (DZHK), partner site Greifswald, Greifswald, Germany.
  • Kessler T; Klinik für Herz-und Kreislauferkrankungen, Deutsches Herzzentrum München, School of Medicine, Technical University of Munich, Munich, Germany.
  • Jamshidi Y; Klinik für Herz-und Kreislauferkrankungen, Deutsches Herzzentrum München, School of Medicine, Technical University of Munich, Munich, Germany.
  • van den Berg ME; Genetics Research Centre, Institute of Molecular and Clinical Sciences, Saint George's University of London, London, United Kingdom.
  • Kaess B; Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Nelson CP; Medizinische Klinik I, St. Josefs-Hospital, Wiesbaden, Germany.
  • Bastiaenen R; Department of Cardiovascular Sciences, BHF Cardiovascular Research Centre, Leicester, United Kingdom.
  • De Bortoli M; National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, University of Leicester, Leicester, United Kingdom.
  • Rossini A; Cardiology Clinical Academic Group, Institute of Molecular and Clinical Sciences, Saint George's, University of London, London, United Kingdom.
  • Deisenhofer I; Eurac Research, Institute for Biomedicine, affiliated with the University of Lübeck, Bolzano, Italy.
  • Stark K; Eurac Research, Institute for Biomedicine, affiliated with the University of Lübeck, Bolzano, Italy.
  • Assa S; Klinik für Herz-und Kreislauferkrankungen, Deutsches Herzzentrum München, School of Medicine, Technical University of Munich, Munich, Germany.
  • Braund PS; Department of Genetic Epidemiology, University Regensburg, Regensburg, Germany.
  • Cabrera C; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Dominiczak AF; Department of Cardiovascular Sciences, BHF Cardiovascular Research Centre, Leicester, United Kingdom.
  • Gögele M; National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, University of Leicester, Leicester, United Kingdom.
  • Hall LM; Clinical Pharmacology, William Harvey Research Institute, and.
  • Ikram MA; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom.
  • Kavousi M; Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London, London, United Kingdom, and School of Medicine and Dentistry, Charterhouse Square, London, United Kingdom.
  • Lackner KJ; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.
  • Müller C; Department of Cardiovascular Sciences, BHF Cardiovascular Research Centre, Leicester, United Kingdom.
  • Münzel T; National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, University of Leicester, Leicester, United Kingdom.
  • Nauck M; Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Padmanabhan S; Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Pfeiffer N; Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of the Johannes Gutenberg, University Mainz, Mainz, Germany.
  • Spector TD; DZHK, partner site Rhine-Main, Mainz, Germany.
  • Verweij N; University Heart & Vascular Center Hamburg, Hamburg, Germany.
  • Völker U; DZHK, partner site Hamburg/Kiel/Lübeck, Hamburg, Germany.
  • Warren HR; DZHK, partner site Rhine-Main, Mainz, Germany.
  • Zafar M; Cardiology I, Center for Cardiology, University Medical Center of the Johannes Gutenberg, University Mainz, Mainz, Germany.
  • Felix SB; German Center for Cardiovascular Research (DZHK), partner site Greifswald, Greifswald, Germany.
  • Kors JA; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
  • Snieder H; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.
  • Munroe PB; Department of Ophthalmology, University Medical Center of the Johannes Gutenberg, University Mainz, Mainz, Germany.
  • Pattaro C; Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.
  • Fuchsberger C; Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Schmidt G; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Nolte IM; German Center for Cardiovascular Research (DZHK), partner site Greifswald, Greifswald, Germany.
  • Schunkert H; Interfaculty Institute for Genetics and Functional Genomics and.
  • Pramstaller PP; Clinical Pharmacology, William Harvey Research Institute, and.
  • Wild PS; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom.
  • van der Harst P; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Stricker BH; German Center for Cardiovascular Research (DZHK), partner site Greifswald, Greifswald, Germany.
  • Schnabel RB; Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany.
  • Samani NJ; Department of Medical Informatics, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Hengstenberg C; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Dörr M; Clinical Pharmacology, William Harvey Research Institute, and.
  • Behr ER; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom.
JCI Insight ; 4(23)2019 12 05.
Article em En | MEDLINE | ID: mdl-31600170
ABSTRACT
BACKGROUNDThe presence of an early repolarization pattern (ERP) on the surface ECG is associated with risk of ventricular fibrillation and sudden cardiac death. Family studies have shown that ERP is a highly heritable trait, but molecular genetic determinants are unknown.METHODSTo identify genetic susceptibility loci for ERP, we performed a GWAS and meta-analysis in 2,181 cases and 23,641 controls of European ancestry.RESULTSWe identified a genome-wide significant (P < 5 × 10-8) locus in the potassium voltage-gated channel subfamily D member 3 (KCND3) gene that was successfully replicated in additional 1,124 cases and 12,510 controls. A subsequent joint meta-analysis of the discovery and replication cohorts identified rs1545300 as the lead SNP at the KCND3 locus (OR 0.82 per minor T allele, P = 7.7 × 10-12) but did not reveal additional loci. Colocalization analyses indicate causal effects of KCND3 gene expression levels on ERP in both cardiac left ventricle and tibial artery.CONCLUSIONSIn this study, we identified for the first time to our knowledge a genome-wide significant association of a genetic variant with ERP. Our findings of a locus in the KCND3 gene provide insights not only into the genetic determinants but also into the pathophysiological mechanism of ERP, discovering a promising candidate for functional studies.FUNDINGThis project was funded by the German Center for Cardiovascular Research (DZHK Shared Expertise SE081 - STATS). For detailed funding information per study, see the Supplemental Acknowledgments.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Ventricular / Predisposição Genética para Doença / Eletrocardiografia / Canais de Potássio Shal / Estudo de Associação Genômica Ampla Tipo de estudo: Prognostic_studies / Systematic_reviews Idioma: En Revista: JCI Insight Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Ventricular / Predisposição Genética para Doença / Eletrocardiografia / Canais de Potássio Shal / Estudo de Associação Genômica Ampla Tipo de estudo: Prognostic_studies / Systematic_reviews Idioma: En Revista: JCI Insight Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha